Zhejiang Jingxin Pharmaceutical
Launch date
Employees
Market cap
€1.2b
Enterprise valuation
€1.1b (Public information from Sep 2024)
Share price
CNY10.61 002020.SZ
Shaoxing Zhejiang (HQ & founding location)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.3b | 3.3b | 3.8b | 4.0b | 4.4b | 5.0b | 5.8b |
| % growth | (11 %) | 2 % | 13 % | 6 % | 11 % | 13 % | 15 % |
| EBITDA | 881m | 864m | 939m | 919m | 1.1b | 1.2b | 1.4b |
| % EBITDA margin | 27 % | 26 % | 25 % | 23 % | 24 % | 24 % | 24 % |
| Profit | 653m | 614m | 662m | 619m | 684m | 799m | 955m |
| % profit margin | 20 % | 18 % | 18 % | 15 % | 15 % | 16 % | 17 % |
| EV / revenue | 2.0x | 2.5x | 2.6x | 2.7x | 2.2x | 1.9x | 1.7x |
| EV / EBITDA | 7.5x | 9.5x | 10.6x | 11.9x | 9.1x | 8.1x | 6.9x |
| R&D budget | 259m | 329m | 367m | 401m | - | - | - |
| R&D % of revenue | 8 % | 10 % | 10 % | 10 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Zhejiang Jingxin Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
